Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1426 to 1440 of 2042 results for guidelines

  1. Avoidance of aspiration pneumonia: Does the withdrawal of oral liquids or the use of modified (thickened) oral fluids prevent the development of aspiration pneumonia after an acute stroke?

    after an acute stroke are at higher risk of aspiration pneumonia. The guideline development group considered how best to reduce the...

    Research recommendation
    Published
    11 May 2022

  2. Targeted interventions to support and improve decision-making capacity for treatment:- What is the effectiveness and cost effectiveness of different targeted interventions (speech and language therapy and psychological and psychosocial interventions) to support and improve decision-making capacity for treatment in specific groups?

    the studies were limited in number and generally of low quality. The guideline committee agreed that further research in this area...

    Research recommendation
    Published
    18 December 2018

  3. Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis:- A randomised controlled trial should be undertaken to evaluate the clinical and cost effectiveness of stopping intravenous antibiotic therapy and switching to oral therapy within the first 24 hours of treatment in patients with neutropenic sepsis who are having treatment with intravenous antibiotics. The outcomes to be measured are overtreatment, death, need for critical care, length of hospital stay, duration of fever and quality of life.

    treatment at a variety of time points. A meta-regression undertaken by the Guideline Development Group suggested that very early (before...

    Research recommendation
    Published
    9 June 2015

  4. Radiofrequency denervation:- What is the clinical and cost effectiveness of radiofrequency denervation for chronic low back pain in the long term?

    unreasonable clinical expectation. The economic model presented in this guideline suggested that radiofrequency denervation is likely to...

    Research recommendation
    Published
    13 February 2017

  5. Devices for remote monitoring of Parkinson's disease (DG51)

    Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease

    Diagnostics guidance
    Last updated
    25 January 2024
    View recommendations

    Sections for DG51

  6. Podcasts

    Our NICE talks podcasts bring you the real life experiences of people working within the NHS, public health and social care.

    News

  7. Indwelling urinary catheters: antibiotic prophylaxis:- When recatheterising patients who have a long-term indwelling urinary catheter, what is the clinical and cost effectiveness of single-dose antibiotic prophylaxis in reducing symptomatic urinary tract infections in patients with a history of urinary tract infections associated with catheter change?

    develop future guidance (the recommendation on this topic in the current guideline was based on GDG consensus). A randomised controlled...

    Research recommendation
    Published
    9 June 2015

  8. Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA543)

    Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis in adults after inadequate response to DMARDs.

    Technology appraisal guidance
    Published
    3 October 2018
    View recommendations

    Sections for TA543

  9. Ravulizumab for treating atypical haemolytic uraemic syndrome (TA710)

    Evidence-based recommendations on ravulizumab (Ultomiris) for treating atypical haemolytic uraemic syndrome in people weighing 10 kg or more.

    Technology appraisal guidance
    Published
    23 June 2021
    View recommendations

    Sections for TA710

  10. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    9 March 2022

  11. Video laryngoscopes to help intubation in people with difficult airways (MIB167)

    NICE has developed a medtech innovation briefing (MIB) on video laryngoscopy to help intubation in people with difficult airways .

    Medtech innovation briefing
    Published
    19 December 2018

  12. Guide to the processes of technology appraisal (PMG19)

    Guide to the processes of technology appraisal

  13. Patient self-management plans:- What is the clinical and cost effectiveness of a self-management plan for people with stable angina?

    This research would inform future updates of key recommendations in the guideline. Furthermore the research would be relevant to a...

    Research recommendation
    Published
    9 June 2015

  14. Living-donor liver transplantation (IPG535)

    Evidence-based recommendations on living-donor liver transplantation. This involves replacing a diseased or damaged liver with a healthy one from a living human donor.

    Interventional procedures guidance
    Published
    25 November 2015
    View recommendations

    Sections for IPG535

  15. PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes (MIB312)

    NICE has developed a medtech innovation briefing (MIB) on PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes .

    Medtech innovation briefing
    Published
    13 December 2022